Related Experiment Video
Updated: Jan 7, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Clinical Manifestations
Fareshte Erani1, Caitlin M Terao2, Shanna Cooper3
1University of California, San Diego, La Jolla, CA, USA.
Background:
Data-driven analyses of neuropsychological measures have identified subtle cognitive decline phenotypes that demonstrate unique associations with Alzheimer's disease risk and progression. While early detection efforts traditionally focus on cognitive and biological markers, neuropsychiatric symptoms (NPS) have emerged as critical predictors of cognitive decline and dementia conversion. The current study examined whether distinct NPS phenotypes were associated with progression to mild cognitive impairment (MCI)/dementia and cognitive decline trajectories.
Method:
A latent class analysis was conducted on 20,599 cognitively unimpaired (CU) older adults in the National Alzheimer's Coordinating Center Uniform Data Set identified NPS phenotypes using item-level variables from the Neuropsychiatric Inventory and Geriatric Depression Scale. Logistic regressions with Tukey-adjusted contrasts assessed odds of progression to MCI/dementia after adjusting for age, sex, education, and years since baseline. Linear mixed-effects models, adjusting for demographics, examined 6-year changes in cognitive composite scores (memory, attention, executive function, and language) by NPS phenotype.
Result:
The best-fiting model had four NPS phenotypes: [1] Low-All; [2] High-Depression; [3] High-Agitation/Anxiety/Irritability, and [4] High-All (Table 1, Figure 1). The High-All group had the greatest progression risk to MCI/dementia, with 3x higher odds than Low-All (p < .001), 2.1x higher odds than High-Depression (p < .001), and 1.6x higher odds than High-Agitation/Anxiety/Irritability (p = .009). The High-Agitation/Anxiety/ Irritability group had 2x higher odds than Low-All (p < .001) and 1.4x higher odds than High-Depression, while the High-Depression group had 1.4x higher odds than Low-All. At baseline, the Low-All group outperformed others across cognitive domains (all ps < .001) except for memory, where High-Depression did not differ (Figure 2). The High-Depression group showed faster decline in attention than Low-All, while the High-All group declined faster in executive functioning (ps < .01). The High-Agitation/Anxiety/Irritability group showed slower memory improvement (p = .003) and faster decline across all other cognitive domains (ps < .01) compared to the Low-All group.
Conclusion:
Distinct NPS phenotypes were observed among CU older adults and were associated with differing risks of MCI/dementia progression and cognitive trajectories. Phenotypes with high NPS, particularly agitation, anxiety, and irritability, showed higher odds of progression than depressive symptoms alone. These findings underscore the value and potential utility of early NPS patterns for predicting cognitive decline and early risk detection.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations
Endocarditis II: Clinical Features of Infective Endocarditis
Heart Failure III: Clinical Manifestations
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Hypertension III: Clinical Manifestations and Diagnostic Studies

